View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 4, 2020

Pakistan’s Byonyks develops device for bloodless dialysis

A biotechnology start-up in Pakistan, led by experts of a US-based company Byonyks Medical Devices, has developed a device, which will make dialysis process bloodless and affordable for kidney patients.

A biotechnology start-up in Pakistan, led by experts of a US-based company Byonyks Medical Devices, has developed a device, which will make dialysis process bloodless and affordable for kidney patients.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Considered to be Pakistan’s first bloodless risk-free dialysis machine, the device has been developed by the company in collaboration with Pakistan’s Ignite, which funds innovative start-ups, and angel investors.

The device, called Robo-Kidney, is designed to enable kidney patients to undergo blood dialysis at home without extracting blood from the body. It also eliminates the chance of contraction of disease such as HIV or hepatitis C infections, a risk usually associated with traditional dialysis practices.

It uses an automated peritoneal dialysis (APD) method of dialysis. The method involves a special machine to removes toxins and excess fluid from the body by instilling fluid in the stomach and subsequently draining it.

Byonyks founder and CEO Farrukh Usman said: “Robo-Kidney is an affordable and bloodless machine that will allow kidney patients to receive dialysis treatment from the comfort of their homes.”

According to reports, the device is currently being evaluated and trial data is being collected for feedback and patient health progress.

The government plans to manufacture the device on a commercial basis after receiving regulatory approvals with the aim of making dialysis affordable and convenient for kidney patients in the country.

Over 20 million people suffer from kidney disease in Pakistan. Kidney transplants and dialysis are the two options available to people with chronic kidney disease (CKD).

Hemodialysis, which is performed at a dialysis centre, is an expensive and time-consuming process, which the patients are required to undergo multiple times a month.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network